Literature DB >> 21868260

Decreased ezrin and paxillin expression in human urothelial bladder tumors correlate with tumor progression.

Afrodite Athanasopoulou1, Panagiotis Aroukatos, Dimitrios Nakas, Maria Repanti, Helen Papadaki, Vasiliki Bravou.   

Abstract

OBJECTIVES: F-actin binding proteins ezrin and paxillin are involved in cell adhesion and cell migration/invasion. The aim of the study was to investigate their role in urothelial bladder carcinogenesis.
MATERIALS AND METHODS: Expression of ezrin and paxillin was studied by immunohistochemistry in 104 and 96 cases of urothelial bladder tumors, respectively. Correlations with clinicopathologic data and expression of p53, E-cadherin, and β-catenin were examined.
RESULTS: Positive ezrin and paxillin protein expression was found in 99% and 93.7% of cases, respectively. Membranous expression of ezrin was significantly lower in high grade tumors and correlated with invasion. Multivariate analysis showed that ezrin is an independent predictor of muscularis propria invasion. Paxillin expression was significantly decreased in urothelial carcinomas compared with tumors of low malignant potential and low paxillin levels also correlated with advancing tumor stage and invasion. A statistically significant correlation was found between membranous ezrin and E-cadherin as well as between ezrin and paxillin expression in urothelial tumors.
CONCLUSIONS: Down-regulation of ezrin and paxillin in urothelial bladder tumors is associated with aggressive tumor features and invasiveness.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  E-cadherin; Ezrin; Invasion; Paxillin; Tumor progression; Urothelial tumors

Mesh:

Substances:

Year:  2011        PMID: 21868260     DOI: 10.1016/j.urolonc.2011.07.003

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  8 in total

1.  MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2.

Authors:  Shao-Qian Cui; Huan Wang
Journal:  Tumour Biol       Date:  2015-04-09

Review 2.  c-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic Cascade.

Authors:  Nancy D Ebelt; Michael A Cantrell; Carla L Van Den Berg
Journal:  Genes Cancer       Date:  2013-09

3.  Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.

Authors:  Christoffer Wennersten; Gustav Andersson; Karolina Boman; Björn Nodin; Alexander Gaber; Karin Jirström
Journal:  Diagn Pathol       Date:  2014-10-03       Impact factor: 2.644

4.  Expression of Paxillin in Benign and Malignant Salivary Gland Tumors.

Authors:  Azadeh Andisheh-Tadbir; Aysuda Afshari; Mohammad Javad Ashraf
Journal:  J Dent (Shiraz)       Date:  2019-12

5.  Fascin-1, ezrin and paxillin contribute to the malignant progression and are predictors of clinical prognosis in laryngeal squamous cell carcinoma.

Authors:  Wei Gao; Chunming Zhang; Yan Feng; Ganggang Chen; Shuxin Wen; Hui Huangfu; Binquan Wang
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

6.  Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.

Authors:  Gustav Andersson; Christoffer Wennersten; Alexander Gaber; Karolina Boman; Björn Nodin; Mathias Uhlén; Ulrika Segersten; Per-Uno Malmström; Karin Jirström
Journal:  BMC Urol       Date:  2014-05-12       Impact factor: 2.264

7.  Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer.

Authors:  Dafina Ilijazi; Walter Pulverer; Iris E Ertl; Ursula Lemberger; Shoji Kimura; Mohammad Abufaraj; David D'Andrea; Benjamin Pradere; Andreas Bruchbacher; Anna Graf; Francesco Soria; Martin Susani; Andrea Haitel; Luca Molinaro; Armin Pycha; Evi Comploj; Stephan Pabinger; Andreas Weinhäusel; Gerda Egger; Shahrokh F Shariat; Melanie R Hassler
Journal:  Cells       Date:  2020-08-05       Impact factor: 6.600

Review 8.  Pathophysiological Roles of Actin-Binding Scaffold Protein, Ezrin.

Authors:  Kotoku Kawaguchi; Shinji Asano
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.